Low-frequency PEMF Therapy in FIBROMYALGIA: A Randomized, Double-blind, Sham-controlled clinical study
PEMF Therapy improves Fibromyalgia pain by improving blood flow and increasing tissue oxygen levels. Those suffering from Fibromyalgia have used a low-frequency PEMF Therapy mat to improve function, chronic pain and fatigue.
The effectiveness of Pulsed Electromagnetic Field therapy has been documented in thousands of clinical research studies worldwide.
To evaluate the clinical effectiveness of low-frequency pulsed electromagnetic field (PEMF) therapy for women with fibromyalgia (FM).
Fifty-six women with FM, aged 18 to 60 years, were randomly assigned to either PEMF or sham therapy. Both the PEMF group (n=28) and the sham group (n=28) participated in therapy, 30 minutes per session, twice a day for 3 weeks. Treatment outcomes were assessed by the fibromyalgia Impact questionnaire (FIQ), visual analog scale (VAS), patient global assessment of response to therapy, Beck Depression Inventory (BDI), and Short-Form 36 health survey (SF-36), after treatment (at 4 wk) and follow-up (at 12 wk).
The PEMF group showed significant improvements in FIQ, VAS pain, BDI score, and SF-36 scale in all domains at the end of therapy. These improvements in FIQ, VAS pain, and SF-36 pain score during follow-up. The sham group also showed improvement was maintained on all outcome measures except total FIQ scores after treatment. At 12 weeks follow-up, only improvements in the BDI and SF-36 scores were present in the sham group.
Low-frequency PEMF therapy might improve function, pain, fatigue, and global status in FM patients.
Click to read the PubMed Study